Arrowhead Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
08.08.23
/
50%
€25.07
Target price
08.08.24
€54.74
Performance (%)
4.63%
Price
12:54
€26.23
Summary
This prediction is currently active. With a performance of 4.63%, the BUY prediction by Royal_Bank_of_Canada for Arrowhead Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 08.08.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arrowhead Pharmaceuticals Inc. | -2.140% | -2.140% |
iShares Core DAX® | -0.116% | 1.953% |
iShares Nasdaq 100 | -2.733% | -1.273% |
iShares Nikkei 225® | -1.721% | 3.263% |
iShares S&P 500 | -1.527% | 0.194% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $60.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€29.40
07.02.24
07.02.24
€46.44
07.02.25
07.02.25
-10.78%
12:54
12:54
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€31.94
16.01.24
16.01.24
€45.92
16.01.25
16.01.25
-17.88%
12:54
12:54
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€22.00
30.11.23
30.11.23
€45.85
30.11.24
30.11.24
19.23%
12:54
12:54